Answer
No, HIV post-exposure prophylaxis is an unapproved and strongly discouraged use of Viramune (nevirapine hemihydrate), with serious hepatotoxicity, including liver failure requiring transplantation, reported in HIV-uninfected individuals receiving multiple doses.
Sources for this answer
- Viramune 50mg/5ml oral SuspensionBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 42Document updated
Sources checked